Showing results (81-90 of 93) with videos related to
Sort By:
Pageof 10
Therapeutic Drug Monitoring|October 16, 1999
Area under the plasma concentration-time curve for total, but not for free, mycophenolic acid increases in the stable phase after renal transplantation: a longitudinal study in pediatric patients. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant RecipientsL T Weber, T Lamersdorf, M Shipkova, et al.Journal of the American Society of Nephrology : JASN|August 11, 1998
Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. German Study group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant RecipientsL T Weber, M Shipkova, T Lamersdorf, et al.Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|August 24, 2006
[Surveillance of infectious foodborne diseases after enactment of the German Protection against Infection Act in 2001. Potentials and requirements]D Werber, M H Kramer, U Buchholz, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 30, 2003
Hemolytic-uremic syndrome associated with enterohemorrhagic Escherichia coli O26:H infection and consumption of unpasteurized cow's milkFranz Allerberger, Alexander W Friedrich, Katharina Grif, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
Shiga toxin activates complement and binds factor H: evidence for an active role of complement in hemolytic uremic syndromeDorothea Orth, Abdul Basit Khan, Asma Naim, et al.Clinical Journal of the American Society of Nephrology : CJASN|December 18, 2012
Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndromeJohannes Hofer, Andreas R Janecke, L B Zimmerhackl, et al.Pediatric Nephrology (Berlin, Germany)|January 17, 2002
The use of mycophenolate mofetil suspension in pediatric renal allograft recipientsT Bunchman, M Navarro, M Broyer, et al.Journal of the American Society of Nephrology : JASN|March 1, 2011
Screening for NPHS2 mutations may help predict FSGS recurrence after transplantationTherese C Jungraithmayr, Katrin Hofer, Pierre Cochat, et al.Transplantation|November 14, 2008
Pharmacokinetics and immunodynamics of basiliximab in pediatric renal transplant recipients on mycophenolate mofetil comedicationBritta Höcker, John M Kovarik, Volker Daniel, et al.Transplantation|April 27, 2007
Five-year outcome in pediatric patients with mycophenolate mofetil-based renal transplantationTherese C Jungraithmayr, Silke Wiesmayr, Astrid Staskewitz, et al.Pageof 10